Loading
Vaccines and Immunoinformatics Approaches / Monoclonal and Polyclonal Antibodies Research · Journal article
The Journal of Immunology · August 1, 2026
Encouraging direction, but not yet definitive.
This in vitro biochemical characterization demonstrates that human IgA binds to recombinantly expressed FcαR from golden hamster and ferret with high affinity, despite structural differences between species. The findings suggest these animal models may be suitable for studying human IgA-mediated immune responses, but no in vivo efficacy, safety, or infection/immunization outcome data are provided.
In vitro biochemical characterization study. Recombinant proteins derived from golden hamster and ferret; human IgA used as comparator ligand. Intervention: Recombinantly expressed and purified hamster IgA and FcαR, ferret IgA and FcαR. Compared with: Human IgA (bound to hamster and ferret FcαR); ferret FcαR and ferret IgA (tested for mutual binding).
Human IgA bound to both hamster and ferret FcαR with high affinity Ferret FcαR and ferret IgA showed no binding to each other Hamster IgA showed greater sequence similarity to human IgA than ferret IgA
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Researchers planning infection or immunization studies in hamsters or ferrets using human IgA-based therapeutics or assessing IgA-mediated immunity may use these findings to support study design and interpretation, though in vivo validation in actual infection or vaccine studies remains needed.
Characterization study demonstrating that golden hamster and ferret FcαR can bind human IgA with high affinity, supporting their use as animal models for human IgA-mediated immunity, though without clinical efficacy or safety data.
As stated by the source record.
Researchers planning infection or immunization studies in hamsters or ferrets using human IgA-based therapeutics or assessing IgA-mediated immunity may use these findings to support study design and interpretation, though in vivo validation in actual infection or vaccine studies remains needed.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Golden hamster (Mesocricetus auratus) and ferret (Mustela putorius furo) are important animal models in studies of human infectious disease. They are used widely to investigate pathogen-spreading mechanisms and host immunology to evaluate the safety and efficacy of small molecules, biologic drugs and vaccines. To this end, immunoglobulin A (IgA) and its Fcα receptor (FcαR) play critical roles in humans but are not well characterized in these 2 species. Golden hamster and ferret IgA and FcαR were recombinantly expressed, purified, and characterized for N-linked glycosylation site occupancy and binding affinity. Based on sequence and structural alignments, hamster IgA showed greater similarity to human IgA than did ferret, and hinge domains in both small animal models suggested greater structural homology to human IgA2 than IgA1. Despite considerable sequence divergence in both immunoglobulins and receptors, and the lack of binding between ferret FcαR and ferret IgA, human IgA bound to both hamster and ferret FcαR with high affinity. Further, differences in dissociation rates were dependent on test format, suggesting that the 2:1 stoichiometry of human FcαR: IgA is recapitulated in these animals. Overall, this work suggests the suitability of these animals to model protection or pathology driven by interactions between human IgA and host FcαR and will aid in critical and confident interpretation of infection and immunization studies in each species.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.